Brokerages predict that Encompass Health Corp (NYSE:EHC) will report $0.89 earnings per share (EPS) for the current quarter, according to Zacks. Seven analysts have provided estimates for Encompass Health’s earnings, with estimates ranging from $0.86 to $0.93. Encompass Health reported earnings of $0.93 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 4.3%. The business is expected to report its next quarterly earnings report after the market closes on Thursday, April 25th.
According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.76 per share for the current fiscal year, with EPS estimates ranging from $3.72 to $3.79. For the next fiscal year, analysts anticipate that the business will post earnings of $3.92 per share, with EPS estimates ranging from $3.82 to $4.00. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that cover Encompass Health.
Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.79 by $0.01. The business had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Encompass Health had a return on equity of 23.74% and a net margin of 6.83%.
Separately, ValuEngine upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $75.57.
NYSE:EHC traded up $3.56 during trading hours on Friday, reaching $61.27. 2,235,258 shares of the company traded hands, compared to its average volume of 799,153. The stock has a market capitalization of $6.05 billion, a price-to-earnings ratio of 16.88, a PEG ratio of 1.58 and a beta of 0.71. Encompass Health has a 1 year low of $56.24 and a 1 year high of $82.46. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.59.
The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date was Friday, March 29th. Encompass Health’s payout ratio is 29.75%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: Stochastic Momentum Index (SMI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.